Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

French clinics informed on glucose monitor choice:

This article was originally published in Clinica

Executive Summary

How to choose a blood glucose monitor for use in the hospital environment is a subject being tackled at present by the French healthcare products safety agency, AFSSAPS. It has posted a notice on its website alerting healthcare professionals to the factors that should influence their choice, and to possible complications with different types of monitors. These recommendations, it says, should be followed during the tendering process. The agency instructs hospitals to first ensure they have an accurate knowledge of their patient profile and of the services that they offer. They should then make themselves aware of the limitations of each of the devices, details of which are clearly set out in manuals and other notices.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT052876

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel